SST and Alzheimer disease: Pathogenesis of the disease was further associated with somatostatin (SST) inhibitory interneuron loss and preservation of intratelencephalic-projecting pyramidal cells was associated with a slower rate of cognitive decline in human postmortem AD samples [44].